Skip to content

Prospective study for Investigation and prevention for HBV reactivation

Prospective study for Investigation and prevention for HBV reactivation - HBV reactivation study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000009491
Enrollment
500
Registered
2020-12-31
Start date
2012-12-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HBV carrier, Past HBV infection

Interventions

None listed

Sponsors

Department of Hepatology, Osaka City University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Positive for HBsAg or anti-HBc, or anti-HBs

Exclusion criteria

Exclusion criteria: Drug allergy for entecavir or HB vaccine

Design outcomes

Primary

MeasureTime frame
Frequency of HBV reactivation

Countries

Japan

Contacts

Public ContactAkihiro Tamori

Osaka City University Graduate School of Medicine Department of Hepatology

atamori@med.osaka-cu.ac.jp06-6645-3811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026